Arcadia Biosciences, Inc. (RKDA)
Track the next or latest earnings date for Arcadia Biosciences, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
stockstotrade.com · 3 days ago
MRVL Stock Climbs As Wall Street Supercharges AI Targets · Valuation ratios tell another part of the story. RKDA trades at roughly 0.41x sales and about 0.68x book value, a discount that says the market has low expectations. For traders, that mix — weak earnings, solid liquidity, and cheap ...
RKDA Stock Slides As Traders Weigh Cash Runway And Chartswww.timothysykes.com · 3 days ago
Arcadia Biosciences Inc. stocks have been trading up by 24.07 percent amid strong optimism from its latest strategic partnership news Key Takeaways Shares of RKDA have slipped from early-month highs near $1.20 to recent closes under $0.95, putting short‑term momentum under pressure.
Rocket Companies (NYSE:RKT): Strongest Q1 Results from the Thrifts & Mortgage Finance Groupfinance.yahoo.com · 1 day ago
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the thrifts & mortgage finance stocks, including Rocket Companies (NYSE:RKT) and its peers.
Arcadia Biosciences stock (US03020Q1058): pipeline update and strategic shift keep investors watchinwww.ad-hoc-news.de · 4 days ago
The company is listed on Nasdaq under the ticker RKDA, making it accessible through standard US brokerage accounts and positioning it within the broader universe of US small-cap biotechnology and ag-tech stocks, as detailed by listing information provided via Nasdaq data as of 04/30/2024.
RXT Stock Rockets On Massive Volume As Traders Pile In - StocksToTradestockstotrade.com · 5 days ago
Rackspace Technology Inc. stocks have been trading down by -15.98 percent amid heightened concerns over its cloud security and service reliability. Key Takeaways RXT has exploded from $1.46 to above $7 this month before pulling back, a huge multi-bagger move that has day traders locked in.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: N/A
Revenue estimate: N/A
Market cap: $3.03M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Mar 19, 2026 | 2025-12-31 | Time not specified | N/A | N/A |